Showing 68,121 - 68,140 results of 102,016 for search '(( 50 ((mean decrease) OR (nn decrease)) ) OR ( 5 ((point decrease) OR (a decrease)) ))', query time: 1.20s Refine Results
  1. 68121

    Nonlinearity-related changes to the average brain regions’ ranking. by Lazaro M. Sanchez-Rodriguez (5278139)

    Published 2018
    “…As the nonlinearity increases, the Spearman’s rho coefficients for the correlation between a ranking and both, the order corresponding to the previous nonlinearity and to the linear case, decrease. …”
  2. 68122

    Interference of weeds on Barbados gooseberry initial development by Ariany G Teixeira (12736859)

    Published 2022
    “…Weed competition led to a decrease in growth and development of Barbados gooseberry reflected in a reduction of up to 40% in yield and 23% in protein content. …”
  3. 68123
  4. 68124

    Optimizing the plastic injection molding process and reducing warpage through response surface methodology by Van-Long Trinh (21338532)

    Published 2025
    “…This paper demonstrates a method to reduce warpage during IMP by using a response surface methodology (RSM). …”
  5. 68125
  6. 68126
  7. 68127

    Functional effect of the Hsa-miR-185* on the <i>TrkB-T1</i> 3′UTR sequence in HEK 293 cell line. by Gilles Maussion (156014)

    Published 2012
    “…<p>A: Schematic representation of <i>TrkB-T1</i> 3′UTR sequence including the five putative binding sites for Hsa-miR-185*. …”
  8. 68128
  9. 68129
  10. 68130
  11. 68131
  12. 68132
  13. 68133
  14. 68134
  15. 68135
  16. 68136

    Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  17. 68137

    Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  18. 68138
  19. 68139

    Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  20. 68140

    Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”